General practitioners' perspectives regarding early developmental surveillance for autism within the australian primary healthcare setting: a qualitative study.
Autism
Families
Growth and development
Healthcare Professional
Primary Healthcare
Screening
Journal
BMC primary care
ISSN: 2731-4553
Titre abrégé: BMC Prim Care
Pays: England
ID NLM: 9918300889006676
Informations de publication
Date de publication:
10 08 2023
10 08 2023
Historique:
received:
20
12
2022
accepted:
01
08
2023
medline:
14
8
2023
pubmed:
11
8
2023
entrez:
10
8
2023
Statut:
epublish
Résumé
Significant challenges remain in the early identification of child developmental disabilities in the community. Implementing supports and services early in the life course has been shown to promote positive developmental outcomes for children at high likelihood of developmental disabilities, including autism. As part of a cluster randomised controlled trial, this study seeks to examine and compare the perspectives and experiences of Australian general practitioners (GPs) in relation to a digital developmental surveillance program for autism and usual care pathway, in general practice clinics. A qualitative research methodology with semi-structured interviews and thematic inductive analysis underpinned by grounded theory was utilised. All GPs from South Western Sydney (NSW) and Melbourne (Victoria) who participated in the main program ("GP Surveillance for Autism") were invited to the interview. GPs who provided consent were interviewed either over online or in-person meeting. Interviews were audio-recorded, transcribed, and coded using NVivo12 software. Inductive interpretive approach was adopted and data were analysed thematically. Twenty-three GPs across the two sites (NSW: n = 11; Victoria: n = 12) agreed to be interviewed; data saturation had reached following this number of participants. Inductive thematic coding and analysis yielded eight major themes and highlighted common enablers such as the role of GPs in early identification and subsequent supports, enhanced communication between clinicians/professionals, relationship-building with patients, and having standardised screening tools. Specific facilitators to the feasibility and acceptability of a digital screening program for the early identification of developmental disabilities, including the early signs of autism, and encouraging research and education for GPs. However, several practical and socioeconomic barriers were identified, in addition to limited knowledge and uptake of child developmental screening tools as well as COVID-19 lockdown impacts. Common and specific recommendations involve supporting GPs in developmental/paediatrics training, streamlined screening process, and funding and resources in the primary healthcare services. The study highlighted the need for practice and policy changes, including further training of GPs alongside sufficient time to complete developmental checks and appropriate financial remuneration through a Medicare billing item. Further research is needed on implementation and scale up of a national surveillance program for early identification of developmental disabilities, including autism.
Sections du résumé
BACKGROUND
Significant challenges remain in the early identification of child developmental disabilities in the community. Implementing supports and services early in the life course has been shown to promote positive developmental outcomes for children at high likelihood of developmental disabilities, including autism. As part of a cluster randomised controlled trial, this study seeks to examine and compare the perspectives and experiences of Australian general practitioners (GPs) in relation to a digital developmental surveillance program for autism and usual care pathway, in general practice clinics.
METHODS
A qualitative research methodology with semi-structured interviews and thematic inductive analysis underpinned by grounded theory was utilised. All GPs from South Western Sydney (NSW) and Melbourne (Victoria) who participated in the main program ("GP Surveillance for Autism") were invited to the interview. GPs who provided consent were interviewed either over online or in-person meeting. Interviews were audio-recorded, transcribed, and coded using NVivo12 software. Inductive interpretive approach was adopted and data were analysed thematically.
RESULTS
Twenty-three GPs across the two sites (NSW: n = 11; Victoria: n = 12) agreed to be interviewed; data saturation had reached following this number of participants. Inductive thematic coding and analysis yielded eight major themes and highlighted common enablers such as the role of GPs in early identification and subsequent supports, enhanced communication between clinicians/professionals, relationship-building with patients, and having standardised screening tools. Specific facilitators to the feasibility and acceptability of a digital screening program for the early identification of developmental disabilities, including the early signs of autism, and encouraging research and education for GPs. However, several practical and socioeconomic barriers were identified, in addition to limited knowledge and uptake of child developmental screening tools as well as COVID-19 lockdown impacts. Common and specific recommendations involve supporting GPs in developmental/paediatrics training, streamlined screening process, and funding and resources in the primary healthcare services.
CONCLUSIONS
The study highlighted the need for practice and policy changes, including further training of GPs alongside sufficient time to complete developmental checks and appropriate financial remuneration through a Medicare billing item. Further research is needed on implementation and scale up of a national surveillance program for early identification of developmental disabilities, including autism.
Identifiants
pubmed: 37563549
doi: 10.1186/s12875-023-02121-6
pii: 10.1186/s12875-023-02121-6
pmc: PMC10416397
doi:
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
159Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
BMC Fam Pract. 2018 Apr 2;19(1):42
pubmed: 29609547
Front Pediatr. 2021 Apr 23;9:640359
pubmed: 33968847
J Ambul Care Manage. 2018 Jan/Mar;41(1):2-14
pubmed: 28990990
Infant Ment Health J. 2010 Jul;31(4):412-431
pubmed: 28543080
Pediatrics. 2015 Oct;136 Suppl 1:S10-40
pubmed: 26430168
Evid Rep Technol Assess (Full Rep). 2011 Mar;(199):1-941
pubmed: 23126607
Prim Health Care Res Dev. 2015 Jul;16(4):356-66
pubmed: 25367194
Health Soc Care Community. 2020 Nov;28(6):1928-1941
pubmed: 32667097
Pediatrics. 2020 Jan;145(1):
pubmed: 31843864
Aust N Z J Psychiatry. 2021 May;55(5):494-505
pubmed: 33461341
Aust J Gen Pract. 2022 Jun;51(6):439-445
pubmed: 35637591
J Gen Intern Med. 2004 Dec;19(12):1228-39
pubmed: 15610334
BMC Fam Pract. 2021 Jun 23;22(1):125
pubmed: 34162343
J Paediatr Child Health. 2021 Jan;57(1):9-11
pubmed: 33159396
BMC Health Serv Res. 2021 Nov 17;21(1):1240
pubmed: 34789234
BMJ Open. 2022 Nov 28;12(11):e064375
pubmed: 36442896
Cancer Med. 2021 Nov;10(22):8040-8057
pubmed: 34608770
Front Neurol. 2023 Jul 07;14:1201265
pubmed: 37483439
BMJ Open. 2020 Jun 17;10(6):e039674
pubmed: 32554730
Med J Aust. 2015 Apr 6;202(6):317-20
pubmed: 25832158
Lancet. 2011 Oct 8;378(9799):1339-53
pubmed: 21944378
Prog Brain Res. 2020;254:271-303
pubmed: 32859292
Aust Health Rev. 2020 Dec;44(6):873-879
pubmed: 31662177
BMC Health Serv Res. 2017 Mar 22;17(1):228
pubmed: 28330490
BMC Pediatr. 2014 Sep 22;14:234
pubmed: 25241772
PLoS One. 2019 Apr 2;14(4):e0214821
pubmed: 30939168
J Autism Dev Disord. 2008 Sep;38(8):1414-25
pubmed: 18240013
Aust N Z J Psychiatry. 2016 Aug;50(8):718-20
pubmed: 27282164
JAMA Netw Open. 2022 Mar 1;5(3):e2146415
pubmed: 35275169
J Prim Health Care. 2016 Jun;8(2):122-9
pubmed: 27477554
BMC Med Educ. 2017 Feb 2;17(1):32
pubmed: 28148254
J Dev Behav Pediatr. 2010 Jun;31(5):376-85
pubmed: 20495475
Int Rev Psychiatry. 2018 Feb;30(1):25-39
pubmed: 29537331
BMC Pediatr. 2020 Jan 18;20(1):21
pubmed: 31952489
J Am Acad Child Adolesc Psychiatry. 2012 Feb;51(2):202-212.e7
pubmed: 22265366
BMJ Open Qual. 2021 Feb;10(1):
pubmed: 33589504
Acad Med. 2014 Sep;89(9):1245-51
pubmed: 24979285